Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans
- 1 September 1992
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (6) , 1149-1157
- https://doi.org/10.1016/0006-2952(92)90379-w
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its ProgenitorsScience, 1991
- Development of antischistosomal agents: Inhibitors of hypoxanthine-guanine phosphoribosyltransferaseDrug Development Research, 1991
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Structures and Mutagenic Properties of Products Obtained byC-Nitrosation of OpipramolHelvetica Chimica Acta, 1987
- Unsymmetrically substituted furoxans. VIII. ChloromethylfuroxansJournal of Heterocyclic Chemistry, 1983
- Strukturuntersuchungen an Oxadiazolring‐SystemenEuropean Journal of Organic Chemistry, 1980
- Mutagenesis by 4-nitrobenzofurazans and furoxansChemico-Biological Interactions, 1977
- Mutagenicity of anti-cancer nitrobenzofuroxansMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1977
- Furazanobenzofuroxan, furazanobenzothiadiazole, and their N-oxides. New class of vasodilator drugsJournal of Medicinal Chemistry, 1974
- Potential Antileukemic and Immunosuppressive Drugs. II. Further Studies with Benzo-2,1,3-oxadiazoles (Benzofurazans) and Their N-Oxides (Benzofuroxans)Journal of Medicinal Chemistry, 1969